Product Information

METFORMIN HCL 850 MG TABLET is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.0257 per EA under NDC 23155084205. Its NADAC has been published 163 times since Oct 11, 2023.

FDA first approved this application on Dec 3, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METFORMIN HCL 850 MG TABLET

metformin hydrochloride
$0.0257per EA

Strength

850 mg/1

NDC

23155084205

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

METFORMIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA213320

FDA Approved

12/3/2021

TE Code

AB

On Market Since

1/19/2023

Pharmacological Classes

Biguanide
Biguanides

Price Statistics

The NADAC for METFORMIN HCL 850 MG TABLET has been published 163 times since Oct 11, 2023, and over the history we have for it it has declined 7.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0257 per EA
All-time high$0.0296 (Dec 13, 2023)
All-time low$0.0196 (May 22, 2024)
52-week high$0.0257
52-week low$0.0227
Median price$0.0239
Average price$0.0238
Largest weekly change+26.0% (Jun 19, 2024)
Weeks tracked163
Tracking sinceOct 11, 2023

Price History

1W

+5.3%

1M

+5.3%

3M

+7.6%

6M

+3.5%

1Y

+13.2%

3Y

-2.9%

5Y

N/A

All

-7.0%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METFORMIN HCL 850 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 850 MG TABLET, manufactured by Heritage Pharmaceuticals Inc., is $0.0257 per EA (NDC 23155084205), effective Nov 18, 2026.

How has the price of METFORMIN HCL 850 MG TABLET changed over time?

Over the history we have for it, the NADAC for METFORMIN HCL 850 MG TABLET has declined 7.0%. It has been tracked across 163 weekly CMS publications since Oct 11, 2023.

What are the highest and lowest recorded NADAC prices for METFORMIN HCL 850 MG TABLET?

Since Oct 11, 2023, the NADAC for METFORMIN HCL 850 MG TABLET has ranged from a low of $0.0196 (May 22, 2024) to a high of $0.0296 (Dec 13, 2023), with a median of $0.0239 per EA.

Are there cheaper alternatives to METFORMIN HCL 850 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METFORMIN HCL 850 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures METFORMIN HCL 850 MG TABLET?

METFORMIN HCL 850 MG TABLET (NDC 23155084205) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.